Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add filters








Language
Year range
1.
2.
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons ; : 406-415, 2010.
Article in Korean | WPRIM | ID: wpr-785012
3.
Journal of the Korean Association of Oral and Maxillofacial Surgeons ; : 466-472, 2010.
Article in Korean | WPRIM | ID: wpr-159814

ABSTRACT

INTRODUCTION: This study examined the effect of recombinant human bone morphogenetic protein (rhBMP)-2 and beta-tricalcium phosphate (beta-TCP) on new bone formation in a rabbit calvarium using a rapid prototype titanium cap (RP Ti cap). MATERIALS AND METHODS: Eight New Zealand white rabbits were used in this study. Hemispherical RP Ti caps (10 mm in diameter) were implanted subperiosteally on the rabbit calvaria. beta-TCP was filled in the RP Ti cap in the control group, and rhBMP-2 soaked beta-TCP was used in experimental group. The rabbits were sacrificed 2 and 4 weeks after the operation. The volume and pattern of newly formed bone was analyzed by micro computed tomography (CT). RESULTS: Macroscopically, there were no abnormal findings in any of the animals. The micro CT images revealed new bone from the calvaria that expanded gradually toward the top of the titanium cap, particularly along the inner surface of the titanium cap in the experimental group at 4 weeks after grafting. There was no significant difference in new bone volume ratio between the control and experimental groups at 2 weeks after grafting. There was a statistically significant difference in the new bone volume ratio between the experimental (14.1+/-1.8 %) and control (7.2+/-1.5 %) groups at 4 weeks after grafting (P<0.01). CONCLUSION: The RP Ti cap can effectively guide new bone formation and rhBMP-2 can induce the new bone formation.


Subject(s)
Animals , Humans , Rabbits , Bone Morphogenetic Protein 2 , Bone Morphogenetic Proteins , Calcium Phosphates , Osteogenesis , Skull , Titanium , Transplants
4.
Journal of the Korean Association of Oral and Maxillofacial Surgeons ; : 490-496, 2010.
Article in Korean | WPRIM | ID: wpr-159811

ABSTRACT

INTRODUCTION: This study examined the effect of a conservative neck dissection in patients with head and neck cancer. MATERIALS AND METHODS: A total of 24 patients, who underwent a conservative neck dissection for the treatment of oral cancer from January 2002 to December 2007, were included. All procedures were performed by one oral and maxillofacial surgeon. The mean age was 58.2 years (range, 19 to 79 years). The medical recordings, pathologic findings, and radiographic findings were evaluated. The mean follow up period was 41.1 months (range, 4 to 88 months). RESULTS: 1. Oral cancer was more common in men than women with a 3:1 ratio. 2. Histopathologically, squamous cell carcinoma(83%) was the most prevalent oral cancer in this study. 3. The most common primary site was the tongue(6 cases, 25%) followed by the mouth floor (5 cases, 21%), buccal mucosa (3 cases, 13%), lower lip, mandible, palate (2 cases, respectively) and salivary gland, retromolar area, oropharynx, alveolus (1 case, each). 4. Three out of the 24 (13%) subjects had a recurrence at the primary sites. 5. Two out of 24 (8%) subjects had a distant metastasis. 6. All 24 patients survived and there were eleven patients who passed 5 years postoperatively. CONCLUSION: A conservative neck dissection is a reliable and effective method for controlling neck node metastases in patients with oral cancer of the N0 or N1 neck node without serious complications.


Subject(s)
Female , Humans , Male , Follow-Up Studies , Head , Lip , Mandible , Medical Records , Mouth Floor , Mouth Mucosa , Mouth Neoplasms , Neck , Neck Dissection , Neoplasm Metastasis , Oropharynx , Palate , Recurrence , Salivary Glands
5.
Journal of Korean Neurosurgical Society ; : 422-424, 2003.
Article in Korean | WPRIM | ID: wpr-109696

ABSTRACT

The authors report two cases of intramedullary metastasis from breast cancer and melanoma respectively. Both patients presented with rapidly progressing paraparesis. They were treated by laminectomy with microsurgical extirpation of the tumor and whole spine irradiation. The patient with melanoma died at 3 months postoperatively and the other with breast cancer is still alive for 40 months after being diagnosed of spinal cord metastasis. The prognosis of intramedullary spinal cord metastasis is known to be poor, however, early diagnosis and radical surgery before irreVersible deterioration of neurologic status can prolong functional survival.


Subject(s)
Humans , Breast Neoplasms , Early Diagnosis , Laminectomy , Melanoma , Neoplasm Metastasis , Paraparesis , Prognosis , Spinal Cord , Spine
6.
Journal of Korean Neurosurgical Society ; : 428-432, 2003.
Article in Korean | WPRIM | ID: wpr-109623

ABSTRACT

OBJECTIVE: Distal posterior cerebral artery(PCA) aneurysms requiring the problematic surgical approaches are rarely encountered. With the development of endovascular treatment, distal PCA aneurysms tend to be treated by endovascular method rather than surgery. We report our experience of distal PCA aneurysms, which were managed mainly by endovascular treatment. METHODS: During the last 5 years, there were five patients harboring distal PCA aneurysms(0.7% among a total 656 intracranial aneurysms). Four patients presented with subarachnoid hemorrhage, while one presented with ipsilateral facial hypesthesia. Four of them were treated by endovascular(Guglielmi detachable coil: GDC) embolization and one was treated by surgical clipping after failure of GDC embolization. RESULTS: Complete obliteration with parent artery encroachment was confirmed in 2 cases. There was one occipital lobe infarction and it resulted in the homonymous quadrantanopsia. In the other case, cerebral infarction did not develop. Incomplete coil embolization was inevitably performed to avoid parent artery occlusion in another two cases. CONCLUSION: Even with the obliteration of the parent artery, distal PCA aneurysms could be treated by use of GDC effectively. Adequate collateral supply to the distal arterial territory seems to contribute to it. Further study needs to be performed to verify this hypothesis.


Subject(s)
Humans , Aneurysm , Arteries , Cerebral Infarction , Embolization, Therapeutic , Hemianopsia , Hypesthesia , Infarction , Intracranial Aneurysm , Occipital Lobe , Parents , Passive Cutaneous Anaphylaxis , Posterior Cerebral Artery , Subarachnoid Hemorrhage , Surgical Instruments
7.
Journal of the Korean Cancer Association ; : 476-486, 2000.
Article in Korean | WPRIM | ID: wpr-82868

ABSTRACT

PURPOSE: MDM-2 is an oncoprotein that inhibits p53 tumor-suppressor protein. These abnor malities have a role in tumorigenesis through inactivation of p53 function. To determine the clini copathological and prognostic value of MDM2 abnormalities in gastric adendegrees Carcinoma, MDM-2& p53 protein expression were analysed in surgically resected materials of gastric adendegrees Carcinoma. MATERIALS AND METHODS: Fifty cases which had got follow-up after surgical resection were immunohistdegrees Chemically studied with p53 and MDM-2 antibodies. We defined variable clinico pathologic factors for expression of p53 and MDM-2 protein and analysed their relationships. RESULTS: Immunohistdegrees Chemical stain revealed expression of MDM-2 protein as a 52.0% (26/50) and p53 protein 20.0% (10/50), respectively. But their expressions were not assdegrees Ciated with clinicopathological factors such as T-factor, N-factor, stage, histology and differentiation. Overall, p53-negative patients seemed to have a better prognosis regardless of MDM-2 protein status (P= 0.057). MDM-2 protein status was considered to have no play as a prognostic factor. CONCLUSION: In the gastric adendegrees Carcinoma, p53 protein expression seemed to have a inverse relationship with clinical outcomes but MDM-2 protein expression, which was observed more frequently than those of p53, seemed not to be prognostic indicator.


Subject(s)
Humans , Antibodies , Carcinogenesis , Follow-Up Studies , Prognosis , Proto-Oncogene Proteins c-mdm2 , Stomach Neoplasms
SELECTION OF CITATIONS
SEARCH DETAIL